25 XP   0   0   10

Nuvation Bio Inc
Buy, Hold or Sell?

Let's analyse Nuvation Bio Inc together

PenkeI guess you are interested in Nuvation Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nuvation Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nuvation Bio Inc

I send you an email if I find something interesting about Nuvation Bio Inc.

Quick analysis of Nuvation Bio Inc (30 sec.)










What can you expect buying and holding a share of Nuvation Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.76
Expected worth in 1 year
$2.53
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-0.23
Return On Investment
-8.8%

For what price can you sell your share?

Current Price per Share
$2.68
Expected price per share
$2.53 - $4.1598
How sure are you?
50%

1. Valuation of Nuvation Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$2.68

Intrinsic Value Per Share

$-3.12 - $-3.60

Total Value Per Share

$-0.35 - $-0.84

2. Growth of Nuvation Bio Inc (5 min.)




Is Nuvation Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$605.1m$684.9m-$64.3m-10.4%

How much money is Nuvation Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$17.7m-$19.6m$1.9m10.9%
Net Profit Margin0.0%4,428.3%--

How much money comes from the company's main activities?

3. Financial Health of Nuvation Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#88 / 1010

Most Revenue
#731 / 1010

Most Profit
#673 / 1010

Most Efficient
#168 / 1010

What can you expect buying and holding a share of Nuvation Bio Inc? (5 min.)

Welcome investor! Nuvation Bio Inc's management wants to use your money to grow the business. In return you get a share of Nuvation Bio Inc.

What can you expect buying and holding a share of Nuvation Bio Inc?

First you should know what it really means to hold a share of Nuvation Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Nuvation Bio Inc is $2.68. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nuvation Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nuvation Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.76. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nuvation Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-2.3%-0.09-3.2%-0.12-4.5%-0.09-3.4%-0.09-3.4%
Usd Book Value Change Per Share-0.03-1.1%-0.06-2.2%-0.10-3.8%0.176.4%0.176.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-1.1%-0.06-2.2%-0.10-3.8%0.176.4%0.176.4%
Usd Price Per Share1.51-1.58-3.17-5.00-5.00-
Price to Earnings Ratio-6.00--4.67--7.01--13.58--13.58-
Price-to-Total Gains Ratio-49.89--30.03--33.40--35.20--35.20-
Price to Book Ratio0.55-0.56-0.99-2.86-2.86-
Price-to-Total Gains Ratio-49.89--30.03--33.40--35.20--35.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.68
Number of shares373
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.17
Usd Total Gains Per Share-0.060.17
Gains per Quarter (373 shares)-21.9064.42
Gains per Year (373 shares)-87.62257.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-88-980258248
20-175-1860515506
30-263-2740773764
40-350-362010311022
50-438-450012881280
60-526-538015461538
70-613-626018041796
80-701-714020612054
90-789-802023192312
100-876-890025772570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.016.00.00.0%0.016.00.00.0%0.016.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.011.01.025.0%4.011.01.025.0%4.011.01.025.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.016.00.0%0.00.016.00.0%0.00.016.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.011.01.025.0%4.011.01.025.0%4.011.01.025.0%

Fundamentals of Nuvation Bio Inc

About Nuvation Bio Inc

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-04-04 21:06:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Nuvation Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nuvation Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nuvation Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4,428.3%-4,428.3%
TTM-5Y1,107.1%-1,107.1%
5Y1,107.1%10Y1,107.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY4,428.3%-288.3%+4,716.6%
5Y1,107.1%-449.1%+1,556.2%
10Y1,107.1%-605.5%+1,712.6%
1.1.2. Return on Assets

Shows how efficient Nuvation Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • -2.2% Return on Assets means that Nuvation Bio Inc generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nuvation Bio Inc:

  • The MRQ is -2.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.2%TTM-2.8%+0.6%
TTM-2.8%YOY-2.8%0.0%
TTM-2.8%5Y-885.7%+882.9%
5Y-885.7%10Y-885.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.2%-13.3%+11.1%
TTM-2.8%-12.8%+10.0%
YOY-2.8%-11.7%+8.9%
5Y-885.7%-13.9%-871.8%
10Y-885.7%-15.7%-870.0%
1.1.3. Return on Equity

Shows how efficient Nuvation Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • -2.3% Return on Equity means Nuvation Bio Inc generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nuvation Bio Inc:

  • The MRQ is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2.9%+0.6%
TTM-2.9%YOY-2.9%+0.0%
TTM-2.9%5Y-4,519.9%+4,517.1%
5Y-4,519.9%10Y-4,519.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%-16.9%+14.6%
TTM-2.9%-16.1%+13.2%
YOY-2.9%-15.1%+12.2%
5Y-4,519.9%-19.3%-4,500.6%
10Y-4,519.9%-20.2%-4,499.7%

1.2. Operating Efficiency of Nuvation Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nuvation Bio Inc is operating .

  • Measures how much profit Nuvation Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nuvation Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY5,204.2%-5,204.2%
TTM-5Y1,301.1%-1,301.1%
5Y1,301.1%10Y1,301.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY5,204.2%-298.2%+5,502.4%
5Y1,301.1%-492.1%+1,793.2%
10Y1,301.1%-632.4%+1,933.5%
1.2.2. Operating Ratio

Measures how efficient Nuvation Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nuvation Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-52.326+52.326
TTM-5Y-13.082+13.082
5Y-13.08210Y-13.0820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-52.3263.890-56.216
5Y-13.0825.739-18.821
10Y-13.0827.876-20.958

1.3. Liquidity of Nuvation Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nuvation Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 44.11 means the company has $44.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nuvation Bio Inc:

  • The MRQ is 44.113. The company is very able to pay all its short-term debts. +2
  • The TTM is 45.588. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ44.113TTM45.588-1.475
TTM45.588YOY41.950+3.638
TTM45.5885Y132.639-87.051
5Y132.63910Y132.6390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ44.1133.890+40.223
TTM45.5884.173+41.415
YOY41.9505.344+36.606
5Y132.6396.126+126.513
10Y132.6396.448+126.191
1.3.2. Quick Ratio

Measures if Nuvation Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 84.69 means the company can pay off $84.69 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nuvation Bio Inc:

  • The MRQ is 84.691. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 87.868. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ84.691TTM87.868-3.176
TTM87.868YOY76.221+11.646
TTM87.8685Y70.141+17.727
5Y70.14110Y70.1410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ84.6913.514+81.177
TTM87.8683.998+83.870
YOY76.2215.380+70.841
5Y70.1416.105+64.036
10Y70.1416.404+63.737

1.4. Solvency of Nuvation Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nuvation Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nuvation Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.03 means that Nuvation Bio Inc assets are financed with 2.6% credit (debt) and the remaining percentage (100% - 2.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nuvation Bio Inc:

  • The MRQ is 0.026. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.027. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.026TTM0.027-0.001
TTM0.027YOY0.032-0.005
TTM0.0275Y0.126-0.099
5Y0.12610Y0.1260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0260.339-0.313
TTM0.0270.336-0.309
YOY0.0320.271-0.239
5Y0.1260.366-0.240
10Y0.1260.389-0.263
1.4.2. Debt to Equity Ratio

Measures if Nuvation Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 2.7% means that company has $0.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nuvation Bio Inc:

  • The MRQ is 0.027. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.028. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.028-0.001
TTM0.028YOY0.033-0.005
TTM0.0285Y0.597-0.570
5Y0.59710Y0.5970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0270.388-0.361
TTM0.0280.402-0.374
YOY0.0330.335-0.302
5Y0.5970.426+0.171
10Y0.5970.461+0.136

2. Market Valuation of Nuvation Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nuvation Bio Inc generates.

  • Above 15 is considered overpriced but always compare Nuvation Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -6.00 means the investor is paying $-6.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nuvation Bio Inc:

  • The EOD is -10.642. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.996. Based on the earnings, the company is expensive. -2
  • The TTM is -4.670. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.642MRQ-5.996-4.646
MRQ-5.996TTM-4.670-1.327
TTM-4.670YOY-7.014+2.345
TTM-4.6705Y-13.578+8.909
5Y-13.57810Y-13.5780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.642-2.264-8.378
MRQ-5.996-2.629-3.367
TTM-4.670-2.680-1.990
YOY-7.014-4.145-2.869
5Y-13.578-6.257-7.321
10Y-13.578-6.254-7.324
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nuvation Bio Inc:

  • The EOD is -9.754. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.496. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.087. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.754MRQ-5.496-4.258
MRQ-5.496TTM-5.087-0.409
TTM-5.087YOY-7.202+2.115
TTM-5.0875Y-18.984+13.896
5Y-18.98410Y-18.9840.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.754-2.973-6.781
MRQ-5.496-3.333-2.163
TTM-5.087-3.553-1.534
YOY-7.202-5.605-1.597
5Y-18.984-8.376-10.608
10Y-18.984-8.865-10.119
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nuvation Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.55 means the investor is paying $0.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nuvation Bio Inc:

  • The EOD is 0.970. Based on the equity, the company is cheap. +2
  • The MRQ is 0.546. Based on the equity, the company is cheap. +2
  • The TTM is 0.556. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.970MRQ0.546+0.423
MRQ0.546TTM0.556-0.009
TTM0.556YOY0.994-0.438
TTM0.5565Y2.858-2.302
5Y2.85810Y2.8580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9701.896-0.926
MRQ0.5462.115-1.569
TTM0.5562.093-1.537
YOY0.9942.884-1.890
5Y2.8583.542-0.684
10Y2.8583.916-1.058
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Nuvation Bio Inc.

3.1. Insider Transactions

Insiders are holding 26.995% of the shares of Nuvation Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-02-21Oleg NodelmanBUY530001.36
2023-02-19Oleg NodelmanBUY51430001.26
2022-12-05Kathryn E FalbergBUY430001.95
2022-12-02Kathryn E FalbergBUY470001.98
2022-11-30Kathryn E FalbergBUY750411.85
2022-04-05Fund V L.p. OmegaSELL25000005.6
2021-12-07Fund V L.p. OmegaSELL14000009.8
2021-11-24Oleg NodelmanBUY1850267.69
2021-11-22Fund V L.p. OmegaSELL2950009.76
2021-11-03Fund V L.p. OmegaSELL20000009.25
2021-10-28Fund V L.p. OmegaSELL10150009.6
2021-07-31Oleg NodelmanBUY565988.64
2021-04-12Oleg NodelmanBUY1330009.49
2021-04-09Oleg NodelmanBUY30000010.03

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Nuvation Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.030-0.059+94%-0.102+236%0.173-118%0.173-118%
Book Value Per Share--2.7632.835-3%3.139-12%2.487+11%2.487+11%
Current Ratio--44.11345.588-3%41.950+5%132.639-67%132.639-67%
Debt To Asset Ratio--0.0260.027-2%0.032-17%0.126-79%0.126-79%
Debt To Equity Ratio--0.0270.028-2%0.033-18%0.597-95%0.597-95%
Dividend Per Share----0%-0%-0%-0%
Eps---0.063-0.087+38%-0.119+90%-0.092+47%-0.092+47%
Free Cash Flow Per Share---0.069-0.078+13%-0.111+61%-0.077+12%-0.077+12%
Free Cash Flow To Equity Per Share---0.068-0.077+13%-0.109+60%0.141-148%0.141-148%
Gross Profit Margin--1.0041.001+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---3.600--------
Intrinsic Value_10Y_min---3.118--------
Intrinsic Value_1Y_max---0.357--------
Intrinsic Value_1Y_min---0.350--------
Intrinsic Value_3Y_max---1.075--------
Intrinsic Value_3Y_min---1.026--------
Intrinsic Value_5Y_max---1.797--------
Intrinsic Value_5Y_min---1.668--------
Market Cap584363280.000+43%330679430.000345272197.500-4%690474310.000-52%1092851451.175-70%1092851451.175-70%
Net Profit Margin----0%44.283-100%11.071-100%11.071-100%
Operating Margin----0%52.042-100%13.011-100%13.011-100%
Operating Ratio----0%-52.3260%-13.0820%-13.0820%
Pb Ratio0.970+44%0.5460.556-2%0.994-45%2.858-81%2.858-81%
Pe Ratio-10.642-77%-5.996-4.670-22%-7.014+17%-13.578+126%-13.578+126%
Price Per Share2.680+44%1.5101.578-4%3.165-52%5.004-70%5.004-70%
Price To Free Cash Flow Ratio-9.754-77%-5.496-5.087-7%-7.202+31%-18.984+245%-18.984+245%
Price To Total Gains Ratio-88.548-77%-49.891-30.029-40%-33.399-33%-35.198-29%-35.198-29%
Quick Ratio--84.69187.868-4%76.221+11%70.141+21%70.141+21%
Return On Assets---0.022-0.028+25%-0.028+25%-8.857+39826%-8.857+39826%
Return On Equity---0.023-0.029+25%-0.029+26%-45.199+198283%-45.199+198283%
Total Gains Per Share---0.030-0.059+94%-0.102+236%0.173-118%0.173-118%
Usd Book Value--605122001.000620603750.250-2%684913250.000-12%543272917.000+11%543272917.000+11%
Usd Book Value Change Per Share---0.030-0.059+94%-0.102+236%0.173-118%0.173-118%
Usd Book Value Per Share--2.7632.835-3%3.139-12%2.487+11%2.487+11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.063-0.087+38%-0.119+90%-0.092+47%-0.092+47%
Usd Free Cash Flow---15042000.000-17017000.000+13%-24119500.000+60%-16855750.000+12%-16855750.000+12%
Usd Free Cash Flow Per Share---0.069-0.078+13%-0.111+61%-0.077+12%-0.077+12%
Usd Free Cash Flow To Equity Per Share---0.068-0.077+13%-0.109+60%0.141-148%0.141-148%
Usd Market Cap584363280.000+43%330679430.000345272197.500-4%690474310.000-52%1092851451.175-70%1092851451.175-70%
Usd Price Per Share2.680+44%1.5101.578-4%3.165-52%5.004-70%5.004-70%
Usd Profit---13787000.000-17751750.000+29%-19688250.000+43%-17391687.500+26%-17391687.500+26%
Usd Revenue----0%-221250.0000%-55312.5000%-55312.5000%
Usd Total Gains Per Share---0.030-0.059+94%-0.102+236%0.173-118%0.173-118%
 EOD+5 -3MRQTTM+21 -9YOY+21 -115Y+17 -1510Y+17 -15

4.2. Fundamental Score

Let's check the fundamental score of Nuvation Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.642
Price to Book Ratio (EOD)Between0-10.970
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than184.691
Current Ratio (MRQ)Greater than144.113
Debt to Asset Ratio (MRQ)Less than10.026
Debt to Equity Ratio (MRQ)Less than10.027
Return on Equity (MRQ)Greater than0.15-0.023
Return on Assets (MRQ)Greater than0.05-0.022
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Nuvation Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.859
Ma 20Greater thanMa 503.129
Ma 50Greater thanMa 1002.492
Ma 100Greater thanMa 2001.999
OpenGreater thanClose2.720
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -5,5262,588-2,938-1,457-4,3951,097-3,2983,479181



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets621,484
Total Liabilities16,362
Total Stockholder Equity605,122
 As reported
Total Liabilities 16,362
Total Stockholder Equity+ 605,122
Total Assets = 621,484

Assets

Total Assets621,484
Total Current Assets616,434
Long-term Assets5,050
Total Current Assets
Cash And Cash Equivalents 42,649
Short-term Investments 568,564
Net Receivables 3,702
Other Current Assets 1,519
Total Current Assets  (as reported)616,434
Total Current Assets  (calculated)616,434
+/-0
Long-term Assets
Property Plant Equipment 4,322
Long-term Assets Other 728
Long-term Assets  (as reported)5,050
Long-term Assets  (calculated)5,050
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,974
Long-term Liabilities2,388
Total Stockholder Equity605,122
Total Current Liabilities
Short-term Debt 1,972
Accounts payable 2,209
Other Current Liabilities 9,793
Total Current Liabilities  (as reported)13,974
Total Current Liabilities  (calculated)13,974
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,035
Long-term Liabilities  (as reported)2,388
Long-term Liabilities  (calculated)2,035
+/- 353
Total Stockholder Equity
Common Stock947,745
Retained Earnings -342,804
Accumulated Other Comprehensive Income 181
Total Stockholder Equity (as reported)605,122
Total Stockholder Equity (calculated)605,122
+/-0
Other
Capital Stock947,745
Cash and Short Term Investments 611,213
Common Stock Shares Outstanding 218,993
Liabilities and Stockholders Equity 621,484
Net Debt -38,642
Net Invested Capital 605,122
Net Working Capital 602,460
Property Plant and Equipment Gross 4,988
Short Long Term Debt Total 4,007



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
96
171
145,499
221,792
832,059
814,263
797,791
776,151
751,805
719,738
686,489
672,141
657,059
641,410
630,870
621,484
621,484630,870641,410657,059672,141686,489719,738751,805776,151797,791814,263832,059221,792145,49917196
   > Total Current Assets 
105,815
3
1,745
220,683
830,866
813,076
796,612
772,073
748,037
714,264
681,389
667,318
652,564
637,226
625,348
616,434
616,434625,348637,226652,564667,318681,389714,264748,037772,073796,612813,076830,866220,6831,7453105,815
       Cash And Cash Equivalents 
0
3
1,345
29,755
638,904
449,533
344,631
132,423
106,207
102,321
138,690
101,099
30,071
50,065
24,395
42,649
42,64924,39550,06530,071101,099138,690102,321106,207132,423344,631449,533638,90429,7551,34530
       Short-term Investments 
0
0
0
185,997
185,809
357,074
447,153
632,969
631,496
601,476
535,255
559,915
616,538
580,835
594,944
568,564
568,564594,944580,835616,538559,915535,255601,476631,496632,969447,153357,074185,809185,997000
       Net Receivables 
700
0
438
1,092
1,015
1,997
1,814
3,039
2,493
2,668
2,350
2,485
2,273
2,795
3,033
3,702
3,7023,0332,7952,2732,4852,3502,6682,4933,0391,8141,9971,0151,0924380700
       Other Current Assets 
0
0
401
914
5,138
4,472
3,014
3,642
7,841
7,799
5,094
3,819
3,682
3,531
2,976
1,519
1,5192,9763,5313,6823,8195,0947,7997,8413,6423,0144,4725,13891440100
   > Long-term Assets 
96
168
143,753
1,109
1,193
1,187
1,179
4,078
3,768
5,474
5,100
4,823
4,495
4,184
5,522
5,050
5,0505,5224,1844,4954,8235,1005,4743,7684,0781,1791,1871,1931,109143,75316896
       Property Plant Equipment 
699
0
688
688
772
766
758
3,657
3,347
5,336
4,962
4,685
4,357
4,046
4,797
4,322
4,3224,7974,0464,3574,6854,9625,3363,3473,6577587667726886880699
       Long Term Investments 
0
0
143,753
0
185,809
357,074
0
0
0
0
0
0
0
0
0
0
0000000000357,074185,8090143,75300
       Long-term Assets Other 
96
168
143,753
421
421
421
421
421
421
138
138
138
138
138
725
728
728725138138138138138421421421421421421143,75316896
> Total Liabilities 
72
147
974
6,708
25,715
25,328
28,425
30,154
28,242
26,659
18,554
17,065
15,986
16,778
19,282
16,362
16,36219,28216,77815,98617,06518,55426,65928,24230,15428,42525,32825,7156,70897414772
   > Total Current Liabilities 
72
147
974
6,551
9,987
10,090
13,308
16,925
21,441
21,274
14,011
13,161
12,551
13,413
16,143
13,974
13,97416,14313,41312,55113,16114,01121,27421,44116,92513,30810,0909,9876,55197414772
       Short-term Debt 
0
80
0
0
0
0
0
863
697
941
1,100
1,206
1,244
1,283
1,915
1,972
1,9721,9151,2831,2441,2061,10094169786300000800
       Short Long Term Debt 
0
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000800
       Accounts payable 
1,497
0
650
2,171
6,003
4,497
5,163
3,925
9,673
12,728
2,995
2,139
2,945
2,577
2,373
2,209
2,2092,3732,5772,9452,1392,99512,7289,6733,9255,1634,4976,0032,17165001,497
       Other Current Liabilities 
72
67
324
4,380
3,984
5,593
8,145
12,137
11,071
7,605
9,916
9,816
8,362
9,553
11,855
9,793
9,79311,8559,5538,3629,8169,9167,60511,07112,1378,1455,5933,9844,3803246772
   > Long-term Liabilities 
0
0
0
157
15,728
15,238
15,117
13,229
6,801
5,385
4,543
3,904
3,435
3,365
3,139
2,388
2,3883,1393,3653,4353,9044,5435,3856,80113,22915,11715,23815,728157000
       Capital Lease Obligations Min Short Term Debt
0
-80
0
0
0
0
0
2,192
2,088
3,752
3,372
3,054
2,727
2,393
2,549
2,035
2,0352,5492,3932,7273,0543,3723,7522,0882,19200000-800
       Warrants
0
0
0
0
114,296
0
0
0
0
0
0
0
0
0
0
0
00000000000114,2960000
       Long-term Liabilities Other 
0
0
0
0
15,561
15,061
14,936
13,229
6,801
5,385
4,543
3,904
3,435
0
0
0
0003,4353,9044,5435,3856,80113,22914,93615,06115,5610000
       Deferred Long Term Liability 
0
0
0
0
167
177
181
0
0
0
0
0
0
0
0
0
0000000001811771670000
> Total Stockholder Equity
24
24
144,525
215,084
806,344
788,935
769,366
745,997
723,563
693,079
667,935
655,076
641,073
624,632
611,588
605,122
605,122611,588624,632641,073655,076667,935693,079723,563745,997769,366788,935806,344215,084144,5252424
   Common Stock
0
0
139,525
289,482
901,720
903,868
906,647
909,985
913,876
919,011
922,209
927,604
932,739
938,395
943,903
947,745
947,745943,903938,395932,739927,604922,209919,011913,876909,985906,647903,868901,720289,482139,52500
   Retained Earnings -342,804-329,017-309,368-288,728-267,002-246,157-218,954-184,096-162,803-137,669-115,690-96,357-75,955-735-1-1
   Capital Surplus 
0
0
0
0
23,219
0
0
0
0
0
0
0
0
0
0
0
0000000000023,2190000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
25
25
5,735
1,557
981
757
388
-1,185
-6,217
-6,978
-8,117
-5,526
-2,938
-4,395
-3,298
0
0-3,298-4,395-2,938-5,526-8,117-6,978-6,217-1,1853887579811,5575,7352525



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-222
Gross Profit-222-222
 
Operating Income (+$)
Gross Profit-222
Operating Expense-99,600
Operating Income-99,822-99,822
 
Operating Expense (+$)
Research Development71,289
Selling General Administrative28,533
Selling And Marketing Expenses222
Operating Expense99,600100,044
 
Net Interest Income (+$)
Interest Income24,611
Interest Expense-0
Other Finance Cost-0
Net Interest Income24,611
 
Pretax Income (+$)
Operating Income-99,822
Net Interest Income24,611
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-75,802-123,842
EBIT - interestExpense = -99,822
-75,802
-75,802
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-99,822-75,802
Earnings Before Interest and Taxes (EBITDA)-99,600
 
After tax Income (+$)
Income Before Tax-75,802
Tax Provision-0
Net Income From Continuing Ops-75,802-75,802
Net Income-75,802
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses99,822
Total Other Income/Expenses Net24,020-24,611
 

Technical Analysis of Nuvation Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nuvation Bio Inc. The general trend of Nuvation Bio Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nuvation Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nuvation Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.095 < 4.095 < 4.1598.

The bearish price targets are: 2.545 > 2.54 > 2.53.

Tweet this
Nuvation Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nuvation Bio Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nuvation Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nuvation Bio Inc. The current macd is 0.02682941.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nuvation Bio Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nuvation Bio Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nuvation Bio Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Nuvation Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartNuvation Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nuvation Bio Inc. The current adx is 20.35.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nuvation Bio Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Nuvation Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nuvation Bio Inc. The current sar is 3.3991344.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Nuvation Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nuvation Bio Inc. The current rsi is 46.86. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Nuvation Bio Inc Daily Relative Strength Index (RSI) ChartNuvation Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nuvation Bio Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nuvation Bio Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Nuvation Bio Inc Daily Stochastic Oscillator ChartNuvation Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nuvation Bio Inc. The current cci is -83.72778734.

Nuvation Bio Inc Daily Commodity Channel Index (CCI) ChartNuvation Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nuvation Bio Inc. The current cmo is -17.93854591.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Nuvation Bio Inc Daily Chande Momentum Oscillator (CMO) ChartNuvation Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nuvation Bio Inc. The current willr is -87.13235294.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Nuvation Bio Inc Daily Williams %R ChartNuvation Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nuvation Bio Inc.

Nuvation Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nuvation Bio Inc. The current atr is 0.27373705.

Nuvation Bio Inc Daily Average True Range (ATR) ChartNuvation Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nuvation Bio Inc. The current obv is -2,719,323.

Nuvation Bio Inc Daily On-Balance Volume (OBV) ChartNuvation Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nuvation Bio Inc. The current mfi is 36.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nuvation Bio Inc Daily Money Flow Index (MFI) ChartNuvation Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nuvation Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-25BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Nuvation Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nuvation Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.859
Ma 20Greater thanMa 503.129
Ma 50Greater thanMa 1002.492
Ma 100Greater thanMa 2001.999
OpenGreater thanClose2.720
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nuvation Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Nuvation Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nuvation Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nuvation Bio Inc

I send you an email if I find something interesting about Nuvation Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Nuvation Bio Inc.

Receive notifications about Nuvation Bio Inc in your mailbox!